Fig. 2.
Overall survival time and cumulative incidence of bone marrow failure for complementation groups FA-A/FA-G and FA-C.
(A) Overall survival time estimated by the Kaplan-Meier method for patients in complementation groups A/G and C. (B) Cumulative incidence of bone marrow failure calculated by a competing-risk approach, in which death is treated as a competing cause of risk, for patients in complementation groups A/G and C.